MetLife Investment Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121K | Buy |
|
|||||
|
2025
Q1 | $108K | Sell |
|
|||||
|
2024
Q4 | $259K | Buy |
|
|||||
|
2024
Q3 | $117K | Buy |
|
|||||
|
2024
Q2 | $107K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $21.7K | Sell |
|
|||||
|
2022
Q4 | $216K | Hold |
|
|||||
|
2022
Q3 | $232K | Buy |
|
|||||
|
2022
Q2 | $189K | Sell |
|
|||||
|
2022
Q1 | $163K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $71K | Sell |
|
|||||
|
2021
Q2 | $268K | Hold |
|
|||||
|
2021
Q1 | $356K | Hold |
|
|||||
|
2020
Q4 | $330K | Hold |
|
|||||
|
2020
Q3 | $472K | Hold |
|
|||||
|
2020
Q2 | $651K | Buy |
|
|||||
|
2020
Q1 | $344K | Hold |
|
|||||
|
2019
Q4 | $650K | Hold |
|
|||||
|
2019
Q3 | $400K | Hold |
|
|||||
|
2019
Q2 | $507K | Hold |
|
|||||
|
2019
Q1 | $438K | Hold |
|
|||||
|
2018
Q4 | $501K | Hold |
|
|||||
|
2018
Q3 | $484K | Hold |
|
|||||
|
2018
Q2 | $427K | Buy |
|
|||||
|
2018
Q1 | $545K | Hold |
|
|||||
|
2017
Q4 | $496K | Buy |
|